Clinton Rolls Out Sanders-Like Healthcare Plan

Hillary Clinton formally adopted a more progressive stance on healthcare in a proposal released Saturday, as part of an effort to appease Bernie Sanders and his supporters.

Read More

Obama Renews Call For A Public Option In Health Law

President Barack Obama Monday called on Congress to revisit the controversial idea of providing a government-run insurance plan as part of the offerings under the Affordable Care Act.

Read More

Brand-Name Drugs’ High Copays Soak Medicare Part D Patients

A new study takes a fresh measure of generic drugs’ price advantages, revealing how much more Medicare Part D patients shelled out in copayments for two popular brand-name drugs in 2013.

Read More

House G.O.P Returns Focus to Obamacare’s Spending Authority

The Obama administration knowingly spent billions in health care dollars without proper congressional authority and went to “great lengths” to impede congressional scrutiny of the money, Republicans on two major House committees said in a report that will be made public on Thursday.

Read More

Court Strikes Down Obama Health Care Rule on Insurance Standards

A federal appeals court has ruled that consumers must be allowed to buy certain types of health insurance that do not meet the stringent standards of the Affordable Care Act, deciding that the administration had gone beyond the terms of federal law.

Read More

Insurers’ Spending on Costly Meds Soared From 2003-14

The latest study of medicine prices finds U.S. insurers' spending on expensive prescription drugs nearly quadrupled from 2003 through 2014, when the number of such prescriptions filled tripled.

Read More

Anthem-Cigna Breakup Could Prompt Chase for Smaller Acquisitions

As doubts continue to swirl around Anthem’s acquisition of Cigna, a potential breakup would leave both insurers looking to acquire smaller plans, according to Bloomberg.

Read More

California Drug Price Plan Is Criticized by Patient Advocates

A state ballot initiative meant to lower prescription drug prices for California faces an expected opponent: the pharmaceutical industry, which has spent almost $70 million to defeat it.

Read More

California Drug Price Transparency Bill Clears Key Committee

A measure that would compel pharmaceutical companies to disclose and justify drug price increases overcame a show of skepticism by Democratic lawmakers on Tuesday afternoon, passing the Assembly Health Committee 12-4 on a party-line vote.

Read More

Reportedly, Aetna Launches Medicare Advantage Asset Sale

Aetna Inc has launched an auction to sell a portfolio of Medicare Advantage assets as it seeks antitrust approval for its $37 billion acquisition of U.S. health insurance peer Humana Inc, according to people familiar with the matter.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square